UNSPSC 51143709: Diphenhydramine/ibuprofen

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN900. This VA Drug Class (CN900) classifies this compound as belonging to the group CNS MEDICATIONS, OTHER.

UNSPSC 51143709 Diphenhydramine/ibuprofen is a Commodity code, but the recent solicitation activity under this code shows a significant mismatch between the nominal scope and actual procurement. Seminole County, Florida posted IFB60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually—neither of which are diphenhydramine or ibuprofen products. The county's procurement targets community health initiatives with quarterly deliveries and includes standard compliance requirements such as drug-free workplace certification, E-Verify authorization, and insurance coverage (workers' compensation, commercial general liability, and professional liability). The contract structure offers an initial two-year term with one-year renewal option and potential FEMA funding, which introduces additional federal compliance obligations under the Clean Air Act and Federal Water Pollution Control Act.

The source contains no other recent state and local opportunities under this code, and the single solicitation present falls outside the code's stated pharmaceutical scope. Seminole County's naloxone and drug deactivation procurement appears to have been tagged to this code incorrectly. No geographic spread, issuing-body mix, or meaningful activity pattern emerges from the available record. Practitioners should verify whether opportunities under UNSPSC 51143709 align with actual diphenhydramine or ibuprofen procurement before committing resources to pursuit under this code.